Enlivex Therapeutics Ltd (ENLV)
1.41
+0.01
(+0.71%)
USD |
NASDAQ |
May 17, 16:00
1.41
0.00 (0.00%)
After-Hours: 20:00
Enlivex Therapeutics Total Assets (Quarterly): 36.83M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 36.83M |
September 30, 2023 | 46.94M |
June 30, 2023 | 53.03M |
March 31, 2023 | 60.02M |
December 31, 2022 | 67.64M |
September 30, 2022 | 72.41M |
June 30, 2022 | 77.34M |
March 31, 2022 | 88.62M |
December 31, 2021 | 95.15M |
September 30, 2021 | 98.17M |
June 30, 2021 | 95.19M |
March 31, 2021 | 95.96M |
December 31, 2020 | 40.36M |
September 30, 2020 | 33.37M |
June 30, 2020 | 35.44M |
March 31, 2020 | 37.65M |
December 31, 2019 | 17.56M |
September 30, 2019 | 19.22M |
June 30, 2019 | 20.83M |
Date | Value |
---|---|
March 31, 2019 | 19.05M |
December 31, 2018 | 11.03M |
June 30, 2018 | 1.704M |
December 31, 2017 | 3.622M |
September 30, 2017 | 4.283M |
June 30, 2017 | 5.514M |
March 31, 2017 | 7.886M |
December 31, 2016 | 10.63M |
September 30, 2016 | 13.37M |
June 30, 2016 | 16.96M |
March 31, 2016 | 22.48M |
December 31, 2015 | 20.52M |
September 30, 2015 | 23.92M |
June 30, 2015 | 26.90M |
March 31, 2015 | 29.85M |
December 31, 2014 | 32.95M |
September 30, 2014 | 34.54M |
June 30, 2014 | 4.516M |
December 31, 2013 | 0.306M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
17.56M
Minimum
Dec 2019
98.17M
Maximum
Sep 2021
57.46M
Average
53.03M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
Compugen Ltd | 121.33M |
Pluri Inc | 36.39M |
BioLine Rx Ltd | 63.92M |
Can Fite Biofarma Ltd | 9.989M |
BiomX Inc | 25.03M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 6.747M |
Shareholders Equity (Quarterly) | 30.08M |